RT Journal Article
SR Electronic
T1 Emergence of porcine delta-coronavirus pathogenic infections among children in Haiti through independent zoonoses and convergent evolution
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.19.21253391
DO 10.1101/2021.03.19.21253391
A1 Lednicky, John A.
A1 Tagliamonte, Massimiliano S.
A1 White, Sarah K.
A1 Elbadry, Maha A.
A1 Alam, Md. Mahbubul
A1 Stephenson, Caroline J.
A1 Bonny, Tania S.
A1 Loeb, Julia C.
A1 Telisma, Taina
A1 Chavannes, Sonese
A1 Ostrov, David A.
A1 Mavian, Carla
A1 De Rochars, Valerie Madsen Beau
A1 Salemi, Marco
A1 Morris, J. Glenn
YR 2021
UL http://medrxiv.org/content/early/2021/03/25/2021.03.19.21253391.abstract
AB Coronaviruses have caused three major epidemics since 2003, including the ongoing SARS-CoV-2 pandemic. In each case, coronavirus emergence in our species has been associated with zoonotic transmissions from animal reservoirs1,2, underscoring how prone such pathogens are to spill over and adapt to new species. Among the four recognized genera of the family Coronaviridae – Alphacoronavirus, Betacoronavirus, Deltacoronavirus, Gammacoronavirus, – human infections reported to date have been limited to alpha- and betacoronaviruses3. We identify, for the first time, porcine deltacoronavirus (PDCoV) strains in plasma samples of three Haitian children with acute undifferentiated febrile illness. Genomic and evolutionary analyses reveal that human infections were the result of at least two independent zoonoses of distinct viral lineages that acquired the same mutational signature in the nsp15 and the spike glycoprotein genes by convergent evolution. In particular, structural analysis predicts that one of the changes in the Spike S1 subunit, which contains the receptor-binding domain, may affect protein’s flexibility and binding to the host cell receptor. Our findings not only underscore the ability of deltacoronaviruses to adapt and potentially lead to human-to-human transmission, but also raise questions about the role of such transmissions in development of pre-existing immunity to other coronaviruses, such as SARS-CoV-2.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWork was supported in part by a grant (R01-AI123657S1) from NIAID to JGM.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study has been reviewed and approved by the University of Florida IRB and the Haitian National IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPDCoV sequences are available through GenBank, with GenBank accession numbers provided in Table 1. Data on strains used in the phylogenetic analysis are included in Supplemental Table S1.